Research Article

Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells

Volume: 38 Number: 3 May 1, 2021
EN

Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells

Abstract

Santolina chameacyparissus (Santo) is an evergreen plant which is traditionally used for its anti-inflammatory effects in various diseases. In this study, we aimed to explore the effects of Santo in non-small cell lung cancer cells. We extracted volatile oil from the plant and evaluated cytotoxicity, apoptosis and motility effects of the extract on two non-small cell lung cancer (NSCLC) cell lines; one is a patient derived and the other one is a commercially available. We also identified its components via GS/MS and investigated possible targets of the major components of the plant using qPCR and docking studies. Cytotoxicity tests showed dose dependent cell killing activity and flow cytometry assays exposed apoptotic effects of Santo. The essential oil also remarkably decreased migration rate of A549 cells, therefore we evaluated the expression levels of epithelial to mesenchymal transition related genes E-cadherin and Vimentin ratio, ZEB1 and SNAIL and another motility related gene Ezrin. Santo did not change the expression of EMT related genes but decreased Ezrin levels. According to the results of the GS/MS analysis, Artemisia ketone and Camphor were identified as major molecules of the extract. Docking analysis also revealed that artemisia ketone, the major component of the Santo extract, potentially showed strong binding to the active site of ezrin protein and both artemisia ketone and camphor had ability to bind DNA. The results of the present study indicate that Santo and its components artemisia ketone and camphor are promising anti-cancer agents, and their potential in targeting DNA and oncogenic proteins in the lung cancer cells seems worth to focus on this plant in cancer related drug discovery science.

Keywords

References

  1. Adams, R.P. (2009). Identification of essential oils components by Gas Cromatography/Mass Spectroscopy. Allured Publishing Co. Carol Stream Illinois.
  2. Antelmi E, Cardone RA, Greco MR et al. 1 integrin binding phosphorylates ezrin at T567 to activate a lipid raft signalsome driving invadopodia activity and invasion. PLoS One. 2013 Sep 24;8(9):e75113.
  3. Ashrafizadeh M, Ahmadi Z, Mohammadinejad R et al. Monoterpenes modulating autophagy: A review study. Basic Clin Pharmacol Toxicol. 2019;00:1-12. Doi: 10.11117bcpt.13282.
  4. Baser K H C, Buchbauer G. Handbook of Essential Oils: Science, Technology and Applications. (2010). CRC Press, Boca Raton, London, New York. ISBN 978-1-4200-6315-8.
  5. Bel Hadj Salah-Fatnassi K, Hassayoun F, Cheraif I, et al. Chemical composition, antibacterial and antifungal activities of flowerhead and root essential oils of Santolina chamaecyparissus L., growing wild in Tunisia. Saudi J Biol Sci. 2017;24(4):875–882. doi:10.1016/j.sjbs.2016.03.005
  6. Boussaada O & Chemli R. (2007) Seasonal Variation of Essential Oil Composition of Citrus Aurantium L. var. amara, Journal of Essential Oil Bearing Plants, 10:2, 109-120, DOI: 10.1080/0972060X.2007.10643528
  7. Celik H, Hong SH, Colon-Lopez DD et al. Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access Malaria Box. Mol Cancer Ther, 2015 Nov;14(11):2497-705
  8. Chahra Boudoukha, Hamama Bouriche, Eduardo Ortega & Abderrahmane Senator (2016) Immunomodulatory effects of Santolina chamaecyparissus leaf extracts on human neutrophil functions,Pharmaceutical Biology, 54:4, 667-673, Doi: 10.3109/13880209.2015.1071853

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

May 1, 2021

Submission Date

January 3, 2021

Acceptance Date

February 2, 2021

Published in Issue

Year 2021 Volume: 38 Number: 3

APA
Saygideger, Y., Saygıdeğer Demir, B., Taskin Tok, T., Avcı, A., Baydar Toprak, O., Sezan, A., & Özyılmaz, E. (2021). Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells. Deneysel Ve Klinik Tıp Dergisi, 38(3), 294-300. https://izlik.org/JA56AF52PY
AMA
1.Saygideger Y, Saygıdeğer Demir B, Taskin Tok T, et al. Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells. J. Exp. Clin. Med. 2021;38(3):294-300. https://izlik.org/JA56AF52PY
Chicago
Saygideger, Yasemin, Burcu Saygıdeğer Demir, Tugba Taskin Tok, et al. 2021. “Antitumoral Effects of Santolina Chameacyparissus on Non-Small Cell Lung Cancer Cells”. Deneysel Ve Klinik Tıp Dergisi 38 (3): 294-300. https://izlik.org/JA56AF52PY.
EndNote
Saygideger Y, Saygıdeğer Demir B, Taskin Tok T, Avcı A, Baydar Toprak O, Sezan A, Özyılmaz E (May 1, 2021) Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells. Deneysel ve Klinik Tıp Dergisi 38 3 294–300.
IEEE
[1]Y. Saygideger et al., “Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells”, J. Exp. Clin. Med., vol. 38, no. 3, pp. 294–300, May 2021, [Online]. Available: https://izlik.org/JA56AF52PY
ISNAD
Saygideger, Yasemin - Saygıdeğer Demir, Burcu - Taskin Tok, Tugba - Avcı, Alper - Baydar Toprak, Oya - Sezan, Aycan - Özyılmaz, Ezgi. “Antitumoral Effects of Santolina Chameacyparissus on Non-Small Cell Lung Cancer Cells”. Deneysel ve Klinik Tıp Dergisi 38/3 (May 1, 2021): 294-300. https://izlik.org/JA56AF52PY.
JAMA
1.Saygideger Y, Saygıdeğer Demir B, Taskin Tok T, Avcı A, Baydar Toprak O, Sezan A, Özyılmaz E. Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells. J. Exp. Clin. Med. 2021;38:294–300.
MLA
Saygideger, Yasemin, et al. “Antitumoral Effects of Santolina Chameacyparissus on Non-Small Cell Lung Cancer Cells”. Deneysel Ve Klinik Tıp Dergisi, vol. 38, no. 3, May 2021, pp. 294-00, https://izlik.org/JA56AF52PY.
Vancouver
1.Yasemin Saygideger, Burcu Saygıdeğer Demir, Tugba Taskin Tok, Alper Avcı, Oya Baydar Toprak, Aycan Sezan, Ezgi Özyılmaz. Antitumoral effects of Santolina chameacyparissus on Non-Small Cell Lung Cancer Cells. J. Exp. Clin. Med. [Internet]. 2021 May 1;38(3):294-300. Available from: https://izlik.org/JA56AF52PY